FDA Drug Application (202323) for CARBIDOPA AND LEVODOPA by ACCORD HLTHCARE

Back to FDA Applications sponsored by ACCORD HLTHCARE

Application Number202323
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG;100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA

Active IngredientCount
List of drugs with Active Ingredient CARBIDOPA16
List of drugs with Active Ingredient LEVODOPA17


Back to FDA Applications sponsored by ACCORD HLTHCARE